Skip to main content
Grant Details

Grant Number: 5R03CA099512-02 Interpret this number
Primary Investigator: Perez-Perez, Guillermo
Organization: New York University School Of Medicine
Project Title: Immune Response to Helicobacter Pylori Vaca as a Marker
Fiscal Year: 2004


DESCRIPTION (provided by applicant): Although gastric cancer mortality rates are gradually decreasing around the world, there are countries, especially in East Asia in which this disease remains prevalent. Helicobacter pylori colonization has been strongly associated with gastric cancer in cohort and case-control studies. Until now, most studies have reported an association between H. pylori and gastric cancer using serological surveys with pools of cell surface preparations from the bacteria as the antigen. However, H. pylori isolates from different geographic areas vary in genotype. We propose to design specific antigenic regions from the major virulence marker of H. pylori (VacA), and by assessing the immune response to this bacterial antigen, determine whether it is a better predictor for the risk of development of gastric cancer in selected populations. For VacA we will obtain peptide antigens specific for the mid region (m1 and m2) because preliminary data suggests that differences in this region may be a predictor of the development of gastric cancer. From a nested case-control study of Japanese-Americans in Hawaii, serum samples were obtained from individuals before they developed gastric cancer over a 21-year follow-up. We also have serum samples from control individuals who did not develop gastric cancer. We expect to find that the immune response to one particular vacA genotype (m1) is predominantly observed in those patients who developed gastric cancer compared to those in whom gastric cancer did not develop. If our hypothesis is correct, we hope to establish a simple and economical serological test to assess the risk of gastric cancer development.


Serological assays for identification of human gastric colonization by Helicobacter pylori strains expressing VacA m1 or m2.
Authors: Ghose C. , Perez-Perez G.I. , Torres V.J. , Crosatti M. , Nomura A. , Peek R.M. , Cover T.L. , Francois F. , Blaser M.J. .
Source: Clinical and vaccine immunology : CVI, 2007 Apr; 14(4), p. 442-50.
EPub date: 2007-01-31.
PMID: 17267587
Related Citations

Immune responses to Helicobacter pylori colonization: mechanisms and clinical outcomes.
Authors: Portal-Celhay C. , Perez-Perez G.I. .
Source: Clinical science (London, England : 1979), 2006 Mar; 110(3), p. 305-14.
PMID: 16464172
Related Citations

Relevance of adjusted cut-off values in commercial serological immunoassays for Helicobacter pylori infection in children.
Authors: Harris P. , Perez-Perez G. , Zylberberg A. , Rollán A. , Serrano C. , Riera F. , Einisman H. , García D. , Viviani P. .
Source: Digestive diseases and sciences, 2005 Nov; 50(11), p. 2103-9.
PMID: 16240223
Related Citations

Seroprevalence of Helicobacter pylori in New York City populations originating in East Asia.
Authors: Perez-Perez G.I. , Olivares A.Z. , Foo F.Y. , Foo S. , Neusy A.J. , Ng C. , Holzman R.S. , Marmor M. , Blaser M.J. .
Source: Journal of urban health : bulletin of the New York Academy of Medicine, 2005 Sep; 82(3), p. 510-6.
EPub date: 2005-07-20.
PMID: 16033932
Related Citations

Back to Top